Module 1 — General Principles of Pharmacology · Course 5 of 5
Role in Module 1: recognizes, assesses, monitors and reports medication-related harm. Recommended after Pharmacogenomics & Therapeutic Drug Monitoring. You can reopen any lesson at any time — your Quick Recall results show which concepts to revisit.
Medication safety, adverse drug reactions, and pharmacovigilance connect prescribing, monitoring, reporting, and systems improvement to prevent medication-related harm.
Course Content
01. Medication Safety as a Systems Discipline
You don't currently have access to this content
02. The Harm Burden of Medication Errors
You don't currently have access to this content
03. The Medication-Use Process Loop
You don't currently have access to this content
04. Defining Adverse Drug Events and Errors
You don't currently have access to this content
05. Latent Failures and Just Culture
You don't currently have access to this content
Quick Recall 1: Systems, process and terminology
You don't currently have access to this content
06. Safeguards for High-Alert Medications
You don't currently have access to this content
07. Look-Alike, Sound-Alike (LASA) and Tall Man Lettering
You don't currently have access to this content
08. Medication Reconciliation During Transitions
You don't currently have access to this content
09. Prescribing Safety and Communication
You don't currently have access to this content
10. Formulation Safety and Dose Dumping
You don't currently have access to this content
11. Administration Safeguards and Technology
You don't currently have access to this content
12. Bedside Monitoring and Patient Equity
You don't currently have access to this content
Quick Recall 2: Error-prevention safeguards
You don't currently have access to this content
13. Framework for Drug Interactions
You don't currently have access to this content
14. Pharmacokinetic (PK) Interaction Safety Workflow
You don't currently have access to this content
15. Pharmacodynamic (PD) Toxic Convergence
You don't currently have access to this content
16. Adverse Drug Reaction (ADR) Terminology
You don't currently have access to this content
17. Type A and Type B Adverse Reactions
You don't currently have access to this content
18. Narrow Therapeutic Index (NTI) Drugs
You don't currently have access to this content
Quick Recall 3: Interactions and ADR classification
You don't currently have access to this content
19. Severe Cutaneous and Immune Reactions
You don't currently have access to this content
20. Organ Toxicity Surveillance Framework
You don't currently have access to this content
21. ADR Causality and Severity Assessment
You don't currently have access to this content
22. Management of Acute Drug Reactions
You don't currently have access to this content
Quick Recall 4: Severe reactions, organ toxicity, causality and management
You don't currently have access to this content
23. Phase IV Surveillance and New Drugs
You don't currently have access to this content
24. Event Reporting Channels
You don't currently have access to this content
25. Regulatory Actions, Boxed Warnings, and REMS
You don't currently have access to this content
26. Root Cause and Systems Analysis
You don't currently have access to this content
27. Deprescribing and Harm Reduction
You don't currently have access to this content
28. Closing the Safety Loop
You don't currently have access to this content
Quick Recall 5: Pharmacovigilance, systems learning and deprescribing
You don't currently have access to this content
Foundations of Mastery: Comprehensive Final Assessment
You don't currently have access to this content
Clinical Application & Mastery Assessment
You don't currently have access to this content